HSCA E&C Letter on Improving Competition in the Generic Marketplace
Dear Chairman Pallone and Ranking Member Walden,
I am writing to you on behalf of the Healthcare Supply Chain Association (HSCA) to thank you for your continued leadership on the important issue of drug pricing and the pressing need to stop anti-competitive abuses that keep drug prices high. HSCA shares your belief that a competitive marketplace will lower the price of generic drugs and help ensure that price spikes for critical generic drugs do not jeopardize patient access to care.
Click here to read the full letter.
Related Posts
HSCA CEO to Lead Panel Discussion on Innovation at AdvaMed’s MedTech Conference
Washington, DC (September 23, 2019) – The Healthcare Supply Chain...
Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Statement on FDA Drug Shortages Task Force Report
Washington, DC (October 29, 2019) – Healthcare Supply Chain Association (HSCA)...
Comments of the Healthcare Supply Chain Association (HSCA) on FDA Request for Comments on Ethylene Oxide Sterilization of Medical Devices
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...